Samsara Biocapital, LLC Top Holdings and 13F Report (2026) About Samsara Biocapital, LLCInvestment ActivitySamsara Biocapital, LLC has $1.03 billion in total holdings as of March 31, 2026.Samsara Biocapital, LLC owns shares of 22 different stocks, but just 6 companies or ETFs make up 80% of its holdings.Approximately 9.82% of the portfolio was purchased this quarter.About 1.14% of the portfolio was sold this quarter.This quarter, Samsara Biocapital, LLC has purchased 21 new stocks and bought additional shares in 2 stocks.Samsara Biocapital, LLC sold shares of 3 stocks and completely divested from 2 stocks this quarter.Largest Holdings Scholar Rock $339,088,572Mineralys Therapeutics $159,045,878ALUMIS INC $139,785,175SEPTERNA INC $75,673,546KALARIS THERAPEUTICS INC $74,710,427 Largest New Holdings this Quarter 85220G109 - SPYGLASS PHARMA INC $54,668,882 Holding00860C102 - AGOMAB THERAPEUTICS NV $6,294,000 Holding19249H103 - Coherus Oncology $5,794,285 Holding Largest Purchases this Quarter SPYGLASS PHARMA INC 2,109,953 shares (about $54.67M)SUTRO BIOPHARMA INC 858,369 shares (about $21.38M)ALUMIS INC 588,235 shares (about $12.96M)AGOMAB THERAPEUTICS NV 600,000 shares (about $6.29M)Coherus Oncology 3,428,571 shares (about $5.79M) Largest Sales this Quarter PALVELLA THERAPEUTICS INC NE 66,385 shares (about $8.27M)ABIVAX SA 18,861 shares (about $2.10M)X4 PHARMACEUTICALS INC 127,434 shares (about $526.30K) Sector Allocation Over TimeMap of 500 Largest Holdings ofSamsara Biocapital, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorSRRKScholar Rock$339,088,5720.0%6,897,65232.9%MedicalMLYSMineralys Therapeutics$159,045,8780.0%5,871,01815.5%MedicalALUMIS INC$139,785,175$12,958,817 â–²10.2%6,345,21913.6%COMSEPTERNA INC$75,673,5460.0%3,149,1287.4%COMKALARIS THERAPEUTICS INC$74,710,4270.0%12,948,0817.3%COMSPYGLASS PHARMA INC$54,668,882$54,668,882 â–²New Holding2,109,9535.3%COM SHSNEUROGENE INC$34,617,2800.0%1,717,1273.4%COMIVAInventiva$28,831,1680.0%5,194,8052.8%MedicalSUTRO BIOPHARMA INC$26,476,142$21,381,972 â–²419.7%1,062,8722.6%COM SHSJADE BIOSCIENCES INC$13,611,6120.0%968,7981.3%COM NEWVTV THERAPEUTICS INC$11,838,3510.0%298,4961.2%CL A NEWAQSTAquestive Therapeutics$10,375,0000.0%2,500,0001.0%MedicalX4 PHARMACEUTICALS INC$7,568,498$526,302 â–¼-6.5%1,832,5660.7%COM NEWNKTXNkarta$7,401,1750.0%3,507,6660.7%MedicalACLXArcellx$6,989,4380.0%60,8730.7%MedicalUPSTREAM BIO INC$6,624,4230.0%736,0470.6%COMABIVAX SA$6,300,294$2,100,172 â–¼-25.0%56,5810.6%SPONSORED ADSAGOMAB THERAPEUTICS NV$6,294,000$6,294,000 â–²New Holding600,0000.6%SPONSORED ADSRANIRani Therapeutics$6,245,8000.0%8,500,0000.6%MedicalCHRSCoherus Oncology$5,794,285$5,794,285 â–²New Holding3,428,5710.6%MedicalPALVELLA THERAPEUTICS INC NE$4,790,549$8,274,891 â–¼-63.3%38,4320.5%COMGOSSGossamer Bio$2,372,6110.0%7,222,5590.2%MedicalCONTINEUM THERAPEUTICS INC$0$825,760 â–¼-100.0%00.0%CL ANUVATION BIO INC$0$40,959 â–¼-100.0%00.0%*W EXP 02/10/202Showing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
